Cordant, Inc. Prime Medicine, Inc. Transaction History

Cordant, Inc.

$192 Billion
Q1 2025

A detailed history of Cordant, Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Cordant, Inc. holds 33 shares of PRME stock, worth $53. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$53

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 Apr 21, 2025	BUY	$1.72 - $3.35 $56 - $110	33 New	33 $66,000

Others Institutions Holding PRME

# of Institutions

140

Shares Held

61M

Call Options Held

42.6K

Put Options Held

173K

Alphabet Inc. Mountain View, CA

15.1M
Shares

$24.4 Million
2.67% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.15M
Shares

$8.34 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.11M
Shares

$8.28 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.98M
Shares

$6.44 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.66M
Shares

$5.92 Million
0.0% of portfolio

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $155M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordant, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cordant, Inc. with notifications on news.

Account